Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Valery Bliskovsky is active.

Publication


Featured researches published by Valery Bliskovsky.


Mbio | 2017

Novel “Superspreader” Bacteriophages Promote Horizontal Gene Transfer by Transformation

Eric C. Keen; Valery Bliskovsky; Francisco Malagon; James D. Baker; Jeffrey S. Prince; James S. Klaus; Sankar Adhya

ABSTRACT Bacteriophages infect an estimated 1023 to 1025 bacterial cells each second, many of which carry physiologically relevant plasmids (e.g., those encoding antibiotic resistance). However, even though phage-plasmid interactions occur on a massive scale and have potentially significant evolutionary, ecological, and biomedical implications, plasmid fate upon phage infection and lysis has not been investigated to date. Here we show that a subset of the natural lytic phage population, which we dub “superspreaders,” releases substantial amounts of intact, transformable plasmid DNA upon lysis, thereby promoting horizontal gene transfer by transformation. Two novel Escherichia coli phage superspreaders, SUSP1 and SUSP2, liberated four evolutionarily distinct plasmids with equal efficiency, including two close relatives of prominent antibiotic resistance vectors in natural environments. SUSP2 also mediated the extensive lateral transfer of antibiotic resistance in unbiased communities of soil bacteria from Maryland and Wyoming. Furthermore, the addition of SUSP2 to cocultures of kanamycin-resistant E. coli and kanamycin-sensitive Bacillus sp. bacteria resulted in roughly 1,000-fold more kanamycin-resistant Bacillus sp. bacteria than arose in phage-free controls. Unlike many other lytic phages, neither SUSP1 nor SUSP2 encodes homologs to known hydrolytic endonucleases, suggesting a simple potential mechanism underlying the superspreading phenotype. Consistent with this model, the deletion of endonuclease IV and the nucleoid-disrupting protein ndd from coliphage T4, a phage known to extensively degrade chromosomal DNA, significantly increased its ability to promote plasmid transformation. Taken together, our results suggest that phage superspreaders may play key roles in microbial evolution and ecology but should be avoided in phage therapy and other medical applications. IMPORTANCE Bacteriophages (phages), viruses that infect bacteria, are the planet’s most numerous biological entities and kill vast numbers of bacteria in natural environments. Many of these bacteria carry plasmids, extrachromosomal DNA elements that frequently encode antibiotic resistance. However, it is largely unknown whether plasmids are destroyed during phage infection or released intact upon phage lysis, whereupon their encoded resistance could be acquired and manifested by other bacteria (transformation). Because phages are being developed to combat antibiotic-resistant bacteria and because transformation is a principal form of horizontal gene transfer, this question has important implications for biomedicine and microbial evolution alike. Here we report the isolation and characterization of two novel Escherichia coli phages, dubbed “superspreaders,” that promote extensive plasmid transformation and efficiently disperse antibiotic resistance genes. Our work suggests that phage superspreaders are not suitable for use in medicine but may help drive bacterial evolution in natural environments. Bacteriophages (phages), viruses that infect bacteria, are the planet’s most numerous biological entities and kill vast numbers of bacteria in natural environments. Many of these bacteria carry plasmids, extrachromosomal DNA elements that frequently encode antibiotic resistance. However, it is largely unknown whether plasmids are destroyed during phage infection or released intact upon phage lysis, whereupon their encoded resistance could be acquired and manifested by other bacteria (transformation). Because phages are being developed to combat antibiotic-resistant bacteria and because transformation is a principal form of horizontal gene transfer, this question has important implications for biomedicine and microbial evolution alike. Here we report the isolation and characterization of two novel Escherichia coli phages, dubbed “superspreaders,” that promote extensive plasmid transformation and efficiently disperse antibiotic resistance genes. Our work suggests that phage superspreaders are not suitable for use in medicine but may help drive bacterial evolution in natural environments.


Genome Announcements | 2015

Genome Sequence of a Fish-Associated Polyomavirus, Black Sea Bass (Centropristis striata) Polyomavirus 1

Alberto Peretti; Peter C. FitzGerald; Valery Bliskovsky; Diana V. Pastrana; Christopher B. Buck

ABSTRACT All known polyomaviruses are associated with mammals or birds. Using virion enrichment, random-primed rolling circle amplification, and deep sequencing, we identified a polyomavirus associated with black sea bass (Centropristis striata). The virus has a variety of novel genetic features, suggesting a long evolutionary separation from polyomaviruses of terrestrial animals.


Genome Announcements | 2013

A Divergent Variant of the Eleventh Human Polyomavirus Species, Saint Louis Polyomavirus

Diana V. Pastrana; Peter C. FitzGerald; Giao Q. Phan; Manish T. Raiji; Philip M. Murphy; David H. McDermott; Daniel Velez; Valery Bliskovsky; Alison A. McBride; Christopher B. Buck

ABSTRACT Saint Louis polyomavirus (STLPyV) was recently discovered in human feces. Using random-primed rolling circle amplification combined with deep sequencing, we have found a divergent variant of STLPyV in a sanitized human skin wart specimen. The result strongly suggests that STLPyV directly infects humans and is not simply a dietary contaminant.


bioRxiv | 2018

Microbiome-TP53 Gene Interaction in Human Lung Cancer

K. Leigh Greathouse; James R White; Ashley J. Vargas; Valery Bliskovsky; Jessica Beck; Natalia von Muhlinen; Eric C. Polley; Elise D. Bowman; Mohammed A. Khan; Ana I. Robles; Tomer Cooks; Bríd M. Ryan; Amiran Dzutsev; Giorgio Trinchieri; Marbin Pineda; Sven Bilke; Paul S. Meltzer; Alexis N. Hokenstad; Tricia M. Stickrod; Marina Walther-Antonio; Joshua P. Earl; Joshua Chang Mell; Jaroslaw Krol; Sergey Balashov; Archana S. Bhat; Garth D. Ehrlich; Alex Valm; Clayton Deming; Sean Conlan; Julia Oh

Background Lung cancer is the leading cancer diagnosis worldwide and the number one cause of cancer deaths. Exposure to cigarette smoke, the primary risk factor in lung cancer, reduces epithelial barrier integrity and increases susceptibility to infections. Herein, we hypothesized that somatic mutations together with cigarette smoke generate a dysbiotic microbiota that is associated with lung carcinogenesis. Using lung tissue from controls (n=33) and cancer cases (n=143), we conducted 16S rRNA bacterial gene sequencing, with RNA-seq data from lung cancer cases in The Cancer Genome Atlas (n=1112) serving as the validation cohort. Results Overall, we demonstrate a lower alpha diversity in normal lung as compared to non-tumor adjacent or tumor tissue. In squamous cell carcinoma (SCC) specifically, a separate group of taxa were identified, in which Acidovorax was enriched in smokers (P =0.0013). Acidovorax temporans was identified by fluorescent in situ hybridization within tumor sections, and confirmed by two separate 16S rRNA strategies. Further, these taxa, including Acidovorax, exhibited higher abundance among the subset of SCC cases with TP53 mutations, an association not seen in adenocarcinomas (AD). Conclusions The results of this comprehensive study show both a microbiome-gene and microbiome-exposure interactions in SCC lung cancer tissue. Specifically, tumors harboring TP53 mutations, which can damage epithelial function, have a unique bacterial consortia which is higher in relative abundance in smoking-associated SCC. Given the significant need for clinical diagnostic tools in lung cancer, this study may provide novel biomarkers for early detection.


Lung Cancer | 2018

HOXA9 Methylation and Blood Vessel Invasion in FFPE Tissues for Prognostic Stratification of Stage I Lung Adenocarcinoma Patients

Delphine Lissa; Teruhide Ishigame; Rintaro Noro; Marguerite J. Tucker; Valery Bliskovsky; Steven Shema; Jessica Beck; Elise D. Bowman; Curtis C. Harris; Ana I. Robles

OBJECTIVES Surgery with curative intent is the standard treatment for stage I lung adenocarcinoma. However, disease recurrence occurs in a third of patients. Prognostic biomarkers are needed to improve postoperative management. Here, we evaluate the utility of Homeobox A9 (HOXA9) promoter methylation, alone or in combination with Blood Vessel Invasion (BVI) assessment, for prognostic stratification of stage I lung adenocarcinoma patients. MATERIALS AND METHODS We developed a Droplet Digital PCR (ddPCR) assay to measure HOXA9 promoter methylation in formalin-fixed paraffin-embedded (FFPE) biospecimens generated during routine pathology. The prognostic value of HOXA9 promoter methylation and BVI, alone and in combination, was evaluated by Kaplan-Meier survival and Cox regression analyses in a cohort of 177 stage I lung adenocarcinoma patients from the NCI-MD study. RESULTS The ddPCR assay showed linearity, sensitivity and specificity for measuring HOXA9 promoter methylation down to 0.1% methylated DNA input. The HOXA9 promoter was methylated de novo in FFPE tumors (P < 0.0001). High methylation was independently associated with worse cancer-specific survival (Hazard Ratio [HR], 3.37; P = 0.0002) and identified high-risk stage IA and IB patients. Addition of this molecular marker improved a risk model comprised of clinical and pathologic parameters (age, gender, race, stage, and smoking history; nested likelihood ratio test; P = 0.0004) and increased the C-index from 0.60 (95% CI 0.51-0.69) to 0.68 (0.60-0.76). High methylation tumors displayed high frequency of TP53 mutations and other molecular characteristics associated with aggressiveness. BVI was independently associated with poor outcome (HR, 2.62; P = 0.054). A score that combined BVI with HOXA9 promoter methylation further stratified high-risk patients (trend P = 0.0001 comparing 0, 1 or 2 positive markers). CONCLUSIONS ddPCR can be used to quantify HOXA9 promoter methylation in FFPE samples. Alone or combined with BVI in a prognostic classifier, HOXA9 promoter methylation could potentially inform the clinical management of patients with early-stage lung adenocarcinoma.


Genome Biology | 2018

Interaction between the microbiome and TP53 in human lung cancer

K. Leigh Greathouse; James R. White; Ashely J. Vargas; Valery Bliskovsky; Jessica Beck; Natalia von Muhlinen; Eric C. Polley; Elise D. Bowman; Mohammed A. Khan; Ana I. Robles; Tomer Cooks; Bríd M. Ryan; Noah Padgett; Amiran Dzutsev; Giorgio Trinchieri; Marbin Pineda; Sven Bilke; Paul S. Meltzer; Alexis N. Hokenstad; Tricia M. Stickrod; Marina Walther-Antonio; Joshua P. Earl; Joshua Chang Mell; Jaroslaw Krol; Sergey Balashov; Archana S. Bhat; Garth D. Ehrlich; Alex Valm; Clayton Deming; Sean Conlan

BackgroundLung cancer is the leading cancer diagnosis worldwide and the number one cause of cancer deaths. Exposure to cigarette smoke, the primary risk factor in lung cancer, reduces epithelial barrier integrity and increases susceptibility to infections. Herein, we hypothesize that somatic mutations together with cigarette smoke generate a dysbiotic microbiota that is associated with lung carcinogenesis. Using lung tissue from 33 controls and 143 cancer cases, we conduct 16S ribosomal RNA (rRNA) bacterial gene sequencing, with RNA-sequencing data from lung cancer cases in The Cancer Genome Atlas serving as the validation cohort.ResultsOverall, we demonstrate a lower alpha diversity in normal lung as compared to non-tumor adjacent or tumor tissue. In squamous cell carcinoma specifically, a separate group of taxa are identified, in which Acidovorax is enriched in smokers. Acidovorax temporans is identified within tumor sections by fluorescent in situ hybridization and confirmed by two separate 16S rRNA strategies. Further, these taxa, including Acidovorax, exhibit higher abundance among the subset of squamous cell carcinoma cases with TP53 mutations, an association not seen in adenocarcinomas.ConclusionsThe results of this comprehensive study show both microbiome-gene and microbiome-exposure interactions in squamous cell carcinoma lung cancer tissue. Specifically, tumors harboring TP53 mutations, which can impair epithelial function, have a unique bacterial consortium that is higher in relative abundance in smoking-associated tumors of this type. Given the significant need for clinical diagnostic tools in lung cancer, this study may provide novel biomarkers for early detection.


Genome Announcements | 2017

Draft Genome Sequence of the Naturally Competent Bacillus simplex Strain WY10

Eric C. Keen; Valery Bliskovsky; Sankar Adhya; Gautam Dantas

ABSTRACT We sequenced a naturally competent bacterial isolate, WY10, cultured from a Wyoming soil sample. Sequence analysis revealed that WY10 is a novel strain of Bacillus simplex. To our knowledge, WY10 is the first B. simplex strain to be characterized as naturally competent for DNA uptake by transformation.


Cancer Research | 2017

Abstract 4925: Microbiome-TP53 gene interaction in human lung cancer

Leigh Greathouse; James R. White; Valery Bliskovsky; Ashley J. Vargas; Eric C. Polley; Elise D. Bowman; Mohammed A. Khan; Ana I. Robles; Bríd M. Ryan; Amiran Dzutsev; Giorgio Trinchieri; Marbin Pineda; Sven Bilke; Paul S. Meltzer; Marina Walther-Antonio; Garth D. Ehrlich; Joshua Chang Mell; Joshua P. Earl; Sergey Balashov; Archana S. Bhat; Alex Valm; Clayton Deming; Sean Conlan; Julia Oh; Julie Segre; Curtis C. Harris

Lung cancer is the leading cancer diagnosis worldwide and the number one cause of cancer deaths. Exposure to cigarette smoke, the primary risk factor in lung cancer, reduces epithelial barrier function and increases susceptibility to infections. Herein, we hypothesized that somatic mutations together with cigarette smoke create a dysbiotic microbiota that is associated with lung carcinogenesis. Using lung tissue from controls (n=33) or cancer cases (n=143), we conducted 16S rRNA gene sequencing (MiSeq), with RNA-seq data from lung cancer cases in The Cancer Genome Atlas (n=1112) serving as the validation cohort. We demonstrate a lower alpha diversity in normal lung as compared to non-tumor adjacent or tumor tissue, indicating a shift in the overall microbial community in lung cancer patients as compared to those without cancer. Lung cancer cases were classified by the relative abundance of two taxa, Variovorax and Streptococcus, with an increase in Variovorax abundance in tumors as compared to non-tumor adjacent paired lung tissue (FDR corrected P=0.013). The species of Variovorax was identified histologically, and also by two additional 16S rRNA strategies (Resphera Insight analysis and PacBio sequencing). A group of taxa were associated with squamous cell carcinoma (SCC), of which Acidovorax were enriched in smokers (P =0.0013). Further, these taxa, including Acidovorax, exhibited higher abundance among the subset of SCC cases with TP53 mutations, an association not seen in adenocarcinomas (AD). Therefore, we observed a microbiome-gene and a microbiome-exposure interaction in SCC lung cancer tissue. Together, these results open the door for future biomarker research that could be used to improve screening and direct mechanistic studies of lung cancer therapy. Citation Format: Leigh Greathouse, James White, Valery Bliskovsky, Ashley Vargas, Eric Polley, Elise Bowman, Mohammed Khan, Ana Robles, Brid Ryan, Amiran Dzutsev, Giorgio Trinchieri, Marbin Pineda, Sven Bilke, Paul Meltzer, Marina Walther-Antonio, Garth Ehrlich, Joshua Mell, Joshua Earl, Sergey Balashov, Archana Bhat, Alex Valm, Clayton Deming, Sean Conlan, Julia Oh, Julie Segre, Curtis Harris. Microbiome-TP53 gene interaction in human lung cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 4925. doi:10.1158/1538-7445.AM2017-4925


Journal for ImmunoTherapy of Cancer | 2015

Study and characterization of mutated antigen specific T cells isolated from fresh tumor and peripheral lymphocytes in cancer patients

Cyrille J. Cohen; Jared J. Gartner; Miryam Horovitz-Fried; Katerina Shamalov; Kasia Trebska-Mcgowan; Valery Bliskovsky; Maria R. Parkhurst; Chen Ankri; Todd D. Prickett; Jessica S. Crystal; Yong Li; Mona El-Gamil; Steven A. Rosenberg; Paul F. Robbins

Meeting abstracts T cell-based immunotherapy shows promise for the successful treatment of advanced cancer. Indeed, adoptively transferred tumor infiltrating T lymphocytes (TIL) that mediated complete regression of metastatic melanoma have been shown to recognize neoantigens/mutated epitopes


Journal of Clinical Investigation | 2015

Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes

Cyrille J. Cohen; Jared J. Gartner; Miryam Horovitz-Fried; Katerina Shamalov; Kasia Trebska-Mcgowan; Valery Bliskovsky; Maria R. Parkhurst; Chen Ankri; Todd D. Prickett; Jessica S Crystal; Yong F. Li; Mona El-Gamil; Steven A. Rosenberg; Paul F. Robbins

Collaboration


Dive into the Valery Bliskovsky's collaboration.

Top Co-Authors

Avatar

Peter C. FitzGerald

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Ana I. Robles

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Elise D. Bowman

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Marbin Pineda

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Paul S. Meltzer

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Christopher B. Buck

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Diana V. Pastrana

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Jared J. Gartner

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Paul F. Robbins

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Steven A. Rosenberg

National Institutes of Health

View shared research outputs
Researchain Logo
Decentralizing Knowledge